<DOC>
	<DOCNO>NCT02570412</DOCNO>
	<brief_summary>Compassionate use aldoxorubicin sarcoma patient fail prior chemotherapy .</brief_summary>
	<brief_title>Compassionate Use Aldoxorubicin Sarcoma Patients Chemotherapy</brief_title>
	<detailed_description>This compassionate use protocol allow sarcoma patient relapse prior therapy eligible protocol involve evaluation aldoxorubicin receive aldoxorubicin .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Metastatic unrectable sarcoma either relapse refractory leat 1 prior chemotherapy immunotherapy regimen standard approve therapy exists Must eligible another CytRxsponsored clinical trial Able provide complete medical record review CytRx Medical Monitor Able receive treatment site participate participate another CytRxsponsored aldoxorubicin trial Capable providing inform consent comply trial procedure ECOG performance status 02 Measurable evaluable tumor lesion accord RECIST 1.1 criterion Women must able become pregnant ( eg postmenopausal least 1 year , surgically sterile , practice adequate birth control method ) duration study Women child bear potential must negative serum urine pregnancy test Screening Visit nonlactating Chemotherapy , palliative surgery and/or radiation treatment le 30 day prior screen nontarget lesion Exposure investigational agent within 30 day screen Central nervous system metastases symptomatic Laboratory value : Screening serum creatinine &gt; 1.5×ULN , ALT &gt; 3×ULN , &gt; 5×ULN liver metastasis present , total bilirubin &gt; 3×ULN , ANC &lt; 1,500/mm3 , platelet concentration &lt; 100,000/mm3 , hematocrit level &lt; 25 % female &lt; 27 % male , coagulation test ( PT , PTT , INR ) &gt; 1.5×ULN Anion gap &gt; 16 meq/L arterial venous blood pH &lt; 7.30 . Clinically evident congestive heart failure &gt; class II New York Heart Association ( NYHA ) guideline Current serious , clinically significant cardiac arrhythmia , define existence absolute arrhythmia ventricular arrhythmia classify Lown III , IV V Baseline QTc &gt; 470 msec and/or previous history QT prolongation take medication . Concomitant use medication associate high incidence QT prolongation allow History sign active coronary artery disease without angina pectoris . Serious myocardial dysfunction define scintigraphically ( eg MUGA , myocardial scintigram ) ultrasound determine absolute LVEF &lt; 45 % predict History HIV infection Active , clinically signifiant serious infection require treatment antibiotic , antiviral antifungal Major surgery within 3 week prior enrollment Substance abuse condition might interfere subject 's participation study evaluation study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>